|
|
|

Wednesday, August 27, 2008
Latest
Chordoma News Headlines
|
|
Chordoma News Headlines
|
|
|
|
|
|
|
|
|
|
|
All Recent Chordoma News Headlines |
|
|
|
|
|
|
Involvement of carotid artery by a chordoma: surgical pitfall
Guney Mehmet Rasit, Ketenci Bulend, Ozay Batuhan, Ozer Nihat, Cimen SerdarNeurology India 2008 56(2):213-214 (Source: Neurology India)...
POSTED 07/20/2008 at 01:47 AM --

|
Chordoma and chondrosarcoma gene profile: implications for immunotherapy
Abstract Chordoma and chondrosarcoma are malignant bone tumors characterized by the abundant production of extracellular matrix. The
resistance of these tumors to conventional therapeutic modalities has prompted us to delineate the gene expression profile
of these two tumor types, with the expectation to identify potential molecular therapeutic targets. Furthermore the transcriptional
profile of chordomas and chrondrosarcomas was compared to a wide variety of sarcomas as well as to that of normal tissues
of similar lineage, to determine whether they express unique gene signatures among other tumors of mesenchymal origin, and
to identify changes associated with malignant transformation. A HG-U133A Affymetrix Chip platform was used to determine the
gene expression signature in 6 chordoma and 14 chondrosarcoma lesions. Validation of selected genes was performed by qPCR
and immunohistochemistry (IHC) on an extended subset of tumors. By unsupervised clustering, chordoma and chondrosarcoma tumors
grouped together in a genomic cluster distinct from that of other sarcoma types. They shared overexpression of many extracellular
matrix genes including aggrecan, type II & X collagen, fibronectin, matrillin 3, high molecular weight-melanoma associated antigen (HMW-MAA), matrix metalloproteinase
MMP-9, and MMP-19. In contrast, T Brachyury and CD24 were selectively expressed in chordomas, as were Keratin 8,13,15,18 and 19. Chondrosarcomas are distinguished by high expression of type IX and XI collagen. Because of its potential usefulness as a target for immunotherapy, the expression of HMW-MAA was analyzed by IHC and was
detected in 62% of chordomas and 48% of chondrosarcomas, respectively. Furthermore, western blotting analysis showed that
HMW-MAA synthesized by chordoma cell lines has a structure similar to that of the antigen synthesized by melanoma cells. In
conclusion, chordomas and chondrosarcomas share a similar gene expression profile of up-regulated extracellular matrix genes.
HMW-MAA represents a potential useful target to apply immunotherapy to these tumors.
Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00262-008-0557-7Authors
Joseph H. Schwab, Memorial Sloan Kettering Cancer Center Department of Surgery, Orthopedic Service New York NY USAPatrick J. Boland, Memorial Sloan Kettering Cancer Center Department of Surgery, Orthopedic Service New York NY USANarasimhan P. Agaram, Memorial Sloan Kettering Cancer Center Department of Pathology 1275 York Ave New York NY 10021 USANicholas D. Socci, Sloan-Kettering Institute Computational Biology Center New York NY USATianhua Guo, Memorial Sloan Kettering Cancer Center Department of Pathology 1275 York Ave New York NY 10021 USAGary C. O’Toole, Memorial Sloan Kettering Cancer Center Department of Surgery, Orthopedic Service New York NY USAXinhui Wang, University of Pittsburgh Cancer Institute Department of Immunology Pittsburgh PA USAElena Ostroumov, University of Calgary Department of Mechanical and Manufacturing Engineering Centre for Bioengineering Research and Education Calgary AB CanadaChristopher J. Hunter, University of Calgary Department of Mechanical and Manufacturing Engineering Centre for Bioengineering Research and Education Calgary AB CanadaJoel A. Block, Rush University Medical Center Rheumatology Section Chicago IL USAStephen Doty, The Hospital for Special Surgery New York NY USASoldano Ferrone, University of Pittsburgh Cancer Institute Departments of Surgery, of Immunology and of Pathology Pittsburgh PA USAJohn H. Healey, Memorial Sloan Kettering Cancer Center Department of Surgery, Orthopedic Service New York NY USACristina R. Antonescu, Memorial Sloan Kettering Cancer Center Department of Pathology 1275 York Ave New York NY 10021 USA
Journal Cancer Immunology, ImmunotherapyOnline ISSN 1432-0851Print ISSN 0340-7004 (Source: Cancer Immunology, Immunotherapy)...
POSTED 07/19/2008 at 08:54 AM --

|
Sacral chordoma: can local recurrence after sacrectomy be predicted?
Sacral Chordoma: Can Local Recurrence After Sacrectomy Be Predicted?
Clin Orthop Relat Res. 2008 Jun 27;
Authors: Hanna SA, Aston WJ, Briggs TW, Cannon SR, Saifuddin A
Surgical resection margins are reportedly the most important predictor of survival and local recurrence with sacral chordomas. We examined the relevance of invasion of the surrounding posterior pelvic musculature (piriformis and gluteus maximus) at initial diagnosis to local recurrence after sacrectomy. We retrospectively reviewed 18 patients with histologically verified sacral chordoma seen at our institution between 1998 and 2005. There were 14 men and four women with a mean age of 65.1 years (range, 31-78 years). The average overall followup was 4.4 years (range, 0.5-10 years), 5.4 years for the living patients (range, 3-10 years), and 2.8 years for the deceased (range, 0.5-5.4 years). Local recurrence occurred in 12 patients (66%) 29 months postoperatively (range, 2-84 months). Six of these patients had wide excisions at initial surgery, five had marginal excisions, and one had an intralesional excision. Ten patients had wide surgical margins, six of whom (60%) had local recurrences. Tumor invasion of adjacent muscles at presentation was present in 14 patients, 12 of whom (85%) had local recurrences. Sacroiliac joint involvement was seen in 10 patients, nine of whom (90%) had local recurrences. The findings suggest obtaining wide surgical margins posteriorly, by excising parts of the piriformis, gluteus maximus, and sacroiliac joints, may result in better local disease control in patients with sacral chordoma. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
PMID: 18584264 [PubMed - as supplied by publisher] (Source: Clinical Orthopaedics and Related Research)...
POSTED 06/26/2008 at 11:00 PM --

|
Safety margins in resection of sacral chordoma: analysis of 18 patients
Abstract
Background Local recurrence after resection of sacral chordoma is a challenging problem for the orthopedic oncologists. That is why analysis
of its margins of safety is of outmost importance.
Material Eighteen cases of sacral chordoma were retrospectively reviewed. All the patients were followed for determination of their
status clinically and radiographically. The surgical margins for every resected tumor were evaluated proximally, ventrally,
and at the postero-lateral aspect of the sacrum.
Results Ventrally, the surgical margins were seven marginal and ten wide margins. Proximally, there were three marginal, nine wide
and five curative margins. Postero-laterally, there were one intra-lesional, one marginal, 12 wide and three curative margins.
Local recurrence encountered postero-laterally in six cases with five wide and one intra-lesional margin. On the other hand,
no local recurrence was disclosed ventrally or proximally despite marginal resections were employed to the ventral resection
in seven and proximally in three cases.
With a mean follow-up of 11 years, six patients died of their disease, and 12 patients were alive. The 5-, 10- and 15-year
survival rates were 81, 70, and 33%, respectively.
Conclusions The appropriate surgical margin for complete removal of the chordoma differs according to the location of the tumor and tissues
involved. Marginal margin ventrally and wide margin proximally are sufficient while postero-laterally including the gluteus
maximus muscles a curative or radical margin seems to be the appropriate surgical margin to prevent tumor recurrence.
Content Type Journal ArticleCategory Orthopaedic SurgeryDOI 10.1007/s00402-008-0674-yAuthors
Adel Refaat Ahmed, Alexandria University Department of Orthopedic Surgery P.O 4 Lambrozo Alexandria Egypt
Journal Archives of Orthopaedic and Trauma SurgeryOnline ISSN 1434-3916Print ISSN 0936-8051 (Source: Archives of Orthopaedic and Trauma Surgery)...
POSTED 06/21/2008 at 01:58 AM --

|
Cranial base chordoma – long term outcome and review of the literature
Summary
Background. The purpose of this study is to clarify the latest long-term therapeutic result for cranial base chordomas. We are seeking
an improvement of long term therapeutic outcome through a review of cranial base chordomas treated in our institute and of
the published literature in the era of multimodality therapy.
Materials and methods. We retrospectively reviewed 13 consecutive patients with cranial base chordoma, including ten males and three females with
mean age of 39.5 years (range 5–76 years).
Results. The method of initial treatment included surgery and post-operative conventional local irradiation (IR) in 9 patients, surgery
and IR followed by post-operative stereotactic radiosurgery (SRS) in 2 patients, surgery as well as SRS in one patients, and
surgery as well as SRS followed by IR in one patient. Subtotal removal (over 95%) was accomplished in eight patients. The
mean follow-up period after completion of surgery and initial radiotherapy was 122 months (median 108 months). According to
the Kaplan-Meier estimate method, the 5-year survival rate was 82.5%: 11 out of 13 patients survived longer than 5 years and
five patients survived longer than 10 years. With a longer follow-up period than the previous reports, our series has provided
a 5-year survival rate comparable to that of proton beam therapy. Although our series indicates a favourable outcome, surgical
resection followed by IR or SRS failed to control tumour growth in five patients.
Conclusions. IR and/or SRS provided results comparable with proton beam or heavy particle therapy in our series of cranial base chordomas
probably because the radiation field must have covered the target of the tumour volume sufficiently, and reduction of gross
tumour volume reduced the target size for radiotherapy. Pursuit of further effective combinations of IR and stereotactic radiotherapy
(SRS, proton beam, heavy particle) after tangible resection, especially for residual and recurrent lesions, will be an acceptable
framework to achieve a better therapeutic outcome for cranial base chordomas than at present.
Content Type Journal ArticleDOI 10.1007/s00701-008-1600-3Authors
Y. Yoneoka, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanI. Tsumanuma, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanM. Fukuda, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanT. Tamura, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanK. Morii, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanR. Tanaka, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata JapanY. Fujii, University of Niigata Department of Neurosurgery, Brain Research Institute Niigata Japan
Journal Acta NeurochirurgicaOnline ISSN 0942-0940Print ISSN 0001-6268 (Source: Acta Neurochirurgica)...
POSTED 06/12/2008 at 01:16 AM --

|
Malignant myoepithelioma of soft tissue: a case report with cytogenetic findings.
Malignant myoepithelioma of soft tissue: a case report with cytogenetic findings.
Cancer Genet Cytogenet. 2008 Jun;183(2):121-4
Authors: Balogh Z, Deák L, Sápi Z
Soft tissue malignant myoepithelioma (STMM) is a particularly rare tumor displaying myoepithelial elements and lacking obvious ductal differentiation. From the one case report with cytogenetic data available in the literature, STMM seems to be a distinct entity with some resemblance to chordoma on the one hand and myoepithelioma on the other. The present case of STMM yielded novel data from high-resolution comparative genomic hybridization (HR-CGH) analysis. An 82-year-old female patient presented with a soft tissue tumor within the deep soft tissues in the right gluteal muscle measuring 16 x 13 x 11 cm. Histologically, the lesion was diagnosed as a myoepithelial carcinoma. Immunohistochemistry was focally positive for pancytokeratin, EMA, S-100 protein, and alpha smooth muscle actin. HR-CGH analysis revealed gains of 1p31 approximately p34, 1q21 approximately q23, 9q12 approximately q33, and 16q22 and losses of 1p11 approximately p22, 1q24 approximately q44, 3p, 10q11.1 approximately q22, 13q, 14q13 approximately q24, and 15q. Subsequent fluorescence in situ hybridization analysis confirmed deletion of 3p, gain of 16q, and monosomy of chromosomes 13 and 15. These results support the hypothesis that STMM is a distinct entity, not sharing the cytogenetic alterations of salivary gland myoepithelial carcinomas and ductal carcinomas of breast with myoepithelial differentiation.
PMID: 18503832 [PubMed - in process] (Source: Cancer Genetics and Cytogenetics)...
POSTED 05/28/2008 at 10:27 AM --

|
Differential diagnosis of dumbbell lesions associated with spinal neural foraminal widening: imaging features.
Differential diagnosis of dumbbell lesions associated with spinal neural foraminal widening: Imaging features.
Eur J Radiol. 2008 May 14;
Authors: Kivrak AS, Koc O, Emlik D, Kiresi D, Odev K, Kalkan E
Computed tomography (CT) and magnetic resonance imaging (MRI) reliably demonstrate typical features of schwannomas or neurofibromas in the vast majority of dumbbell lesions responsible for neural foraminal widening. However, a large variety of unusual lesions which are causes of neural foraminal widening can also be encountered in the spinal neural foramen. Radiologic findings can be helpful in differential diagnosis of lesions of spinal neural foramen including neoplastic lesions such as benign/malign peripheral nerve sheath tumors (PNSTs), solitary bone plasmacytoma (SBP), chondroid chordoma, superior sulcus tumor, metastasis and non-neoplastic lesions such as infectious process (tuberculosis, hydatid cyst), aneurysmal bone cyst (ABC), synovial cyst, traumatic pseudomeningocele, arachnoid cyst, vertebral artery tortuosity. In this article, we discuss CT and MRI findings of dumbbell lesions which are causes of neural foraminal widening.
PMID: 18485652 [PubMed - as supplied by publisher] (Source: European Journal of Radiology)...
POSTED 05/13/2008 at 11:00 PM --

|
Dedifferentiated chordoma: a report of four cases arising 'de novo'.
Dedifferentiated chordoma: A REPORT OF FOUR CASES ARISING 'DE NOVO'.
J Bone Joint Surg Br. 2008 May;90(5):652-6
Authors: Hanna SA, Tirabosco R, Amin A, Pollock RC, Skinner JA, Cannon SR, Saifuddin A, Briggs TW
Dedifferentiated chordoma is a rare and aggressive variant of the conventional tumour in which an area undergoes transformation to a high-grade lesion, typically fibrous histiocytoma, fibrosarcoma, and rarely, osteosarcoma or rhabdomyosarcoma. The dedifferentiated component dictates overall survival, with smaller areas of dedifferentiation carrying a more favourable prognosis. Although it is more commonly diagnosed in recurrences and following radiotherapy, there have been a few reports of spontaneous development. We describe four such cases, which were diagnosed de novo following primary excision, and discuss the associated clinical and radiological features.
PMID: 18450635 [PubMed - in process] (Source: The Journal of Bone and Joint Surgery. British volume)...
POSTED 04/30/2008 at 11:00 PM --

|
Primary reconstruction of pelvic floor defects following sacrectomy using permacoltrade mark graft.
Primary reconstruction of pelvic floor defects following sacrectomy using Permacoltrade mark graft.
Eur J Surg Oncol. 2008 Apr 23;
Authors: Abhinav K, Shaaban M, Raymond T, Oke T, Gullan R, Montgomery AC
AIMS: The large pelvic floor defect following sacrectomy for sacral masses leaves the challenging problem of primary closure and herniation. We present the outcome of primary repair using Permacoltrade mark, a biomaterial made of acellular porcine cross-linked dermal collagen and with similar tensile strength to polypropylene mesh. It is non-allergenic and possibly less likely than synthetic mesh to cause inflammation leading to small bowel adherence; fistula formation and graft extrusion. Following implantation, Permacol is colonized by host cells and resists degradation by host enzymes. METHODS: Three patients had sacrectomy with primary repair of pelvic floor defects between March 2004 and August 2005. Two had excision of sacral chordomas and one excision of a sacrococcygeal teratoma. Repair of the defect was carried out using the Permacol graft, suturing to the sacrum, anococcygeal raphe and ischial spines. Two suction drains were placed superficial to the mesh. RESULTS: All patients had gross en-bloc tumour resections and over a median follow-up period of 1year (range 8-25months), there were no complications related to primary repair. CONCLUSION: Primary closure of a large defect following sacrectomy using a Permacol graft, in our early experience seems to be convenient and safe without the development of herniation.
PMID: 18439796 [PubMed - as supplied by publisher] (Source: European Journal of Surgical Oncology)...
POSTED 04/22/2008 at 11:00 PM --

|
Endoscopic endonasal surgery for clival chordoma and chondrosarcoma
ORL 2008;70:124-129 (DOI:10.1159/000114536) (Source: ORL)...
POSTED 04/11/2008 at 04:27 AM --

|
Craniovertebral junction neoplasms in the pediatric population
Abstract
Introduction The incidence of tumors at the craniovertebral junction in the pediatric population is low. Because of the variable pathology
and the rarity of these tumors, ideal therapies are only now being defined.
Materials and methods Thirty-eight children with tumors affecting the craniocervical junction were encountered between 1991 and 2006. These comprised
neoplasms of osseous origin and neural extramedullary tumors.
Results and discussion Chordomas of the clivus and foramen magnum were seen in eight, fibrous dysplasia in four, aneurysmal bone cysts in four, eosinophilic
granuloma affecting the atlas and axis vertebra in four, Ewing’s sarcoma involving the atlas in two, osteoblastoma in two,
neurenteric cysts in four, meningioma in five, schwannoma in two, and plexiform neurofibromas in three. The location of these
tumors was predominantly ventral, and a very small number had a lateral or dorsal location. The ventral tumors included chordoma,
meningioma, fibrous dysplasia, aneurysmal bone cyst, and osteoblastoma. Plexiform neurofibroma affecting the craniocervical
junction was ventral to the clivus and upper cervical spine causing severe kyphosis of the craniocervical region. Pain in
the head and neck occurred in 70%. Paresthesias and dysesthesias in the hands were seen in 40% and spastic weakness of extremities
in 22%. Cranial nerve palsies were seen in 33%. Twenty-eight percent of children showed dysphagia or dysarthria. The cranial
nerves affected were the vagus followed by hypoglossal and glossopharyngeal nerves. This led to dysphagia, slurred speech,
repeated aspiration pneumonia, and weight loss. The most common findings for chordomas at the craniocervical junction were
isolated hypoglossal nerve palsy. All individuals underwent magnetic resonance imaging, computed tomography, and 3D computed
tomography and angiography. Vertebral angiography was used to understand the dynamics of collateral circulation and tumor
vascularity. Tumor embolization was performed in chordoma and aneurysmal bone cysts. Our experience and results are presented
here.
Content Type Journal ArticleCategory Special Annual IssueDOI 10.1007/s00381-008-0598-4Authors
Arnold H. Menezes, University of Iowa Hospitals and Clinics Department of Neurosurgery 200 Hawkins Drive, 1824 JPP Iowa City IA 52242 USA
Journal Child's Nervous SystemOnline ISSN 1433-0350Print ISSN 0256-7040 (Source: Child's Nervous System)...
POSTED 04/10/2008 at 01:48 AM --

|
Radiotherapy of other sellar lesions
Abstract Radiotherapy has been used as primary or adjuvant treatment in a number of non-adenomatous masses arising from within the
sella. It is particularly important in the therapeutic algorithm of craniopharyngiomas and meningiomas and has also been used
in chordomas/chordosarcomas and less commonly, in other lesions. This review describes the place of irradiation in the management
of these masses.
Content Type Journal ArticleDOI 10.1007/s11102-008-0116-4Authors
N. Karavitaki, Churchill Hospital Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism Old Rd, Headington Oxford OX3 7LJ UK
Journal PituitaryOnline ISSN 1573-7403Print ISSN 1386-341X (Source: Pituitary)...
POSTED 04/04/2008 at 11:53 AM --

|
Surgical approaches: postoperative care and complications “transoral–transpalatopharyngeal approach to the craniocervical junction”
Abstract
Introduction The ventral approach to the craniocervical border has been described for decompression of irreducible extradural pathology.
The procedures utilized encompass the transoropharyngeal and median mandibulotomy with glossotomy and the transpalatal procedures.
This study was aimed to review the utility of the transoral–transpalatopharyngeal approach.
Clinical materials and methods Seven hundred thirty-three patients underwent transpalatopharyngeal approach for decompression of the brain stem and cervicomedullary
junction. Of these, 280 were children below the age of 16 years. The main indication was irreducible ventral pathology compressing
the brain stem and cervicomedullary junction. Two hundred two children had irreducible basilar invagination, 28 had proatlas
segmentation abnormalities, os odontoideum with a dystopic os odontoideum in 30, and spinal tumors in seven (chordoma, fibrous
dysplasia, osteoblastoma). Seven patients with Down’s syndrome and irreducible bony compression of the ventral cervicomedullary
junction were seen. There were six other miscellaneous diagnoses. All children required craniocervical stabilization which
was carried out under the same anesthetic as the transoral procedure.
Operative procedure The procedure entailed fiber-optic intubation. The patient was placed in cervical traction prior to the anterior procedure.
The soft palate was split only in individuals with a short clivus with a high riding clivus-odontoid articulation. Craniocervical
stabilization was performed in the prone position under the same anesthetic.
Results There was one retropharyngeal infection postoperatively. No cesium fluoride leaks were encountered. Velopalatine incompetence
was seen in five children who already had preoperative brain stem dysfunction. Neurological recovery was the rule. Patients
who had preoperative syringohydromyelia had resolution of the syrinx on postoperative magnetic resonance imaging.
Discussion The author’s technique is described. Since 1977, the procedure has been performed in 732 patients (280 children) and has evolved
into a safe and direct approach to the ventral cervicomedullary junction with minimal morbidity and mortality.
Content Type Journal ArticleCategory Special Annual IssueDOI 10.1007/s00381-008-0599-3Authors
Arnold H. Menezes, University of Iowa Hospitals and Clinics Department of Neurosurgery 200 Hawkins Drive, 1824 JPP Iowa City IA 52242 USA
Journal Child's Nervous SystemOnline ISSN 1433-0350Print ISSN 0256-7040 (Source: Child's Nervous System)...
POSTED 04/04/2008 at 11:20 AM --

|
Juvenile intradural chordoma: case report.
Page: E525DOI: 10.1227/01.neu.0000316022.74162.00Authors: Chang, Steven W. M.D.; Gore, Pankaj A. M.D.; Nakaji, Peter M.D.; Rekate, Harold L. M.D. (Source: Neurosurgery)...
POSTED 04/02/2008 at 09:27 AM --

|
Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
Page: 572DOI: 10.1097/PAS.0b013e31815b693aAuthors: Tirabosco, Roberto MD *; Mangham, D. Chas MD + ++; Rosenberg, Andrew E. MD [S]; Vujovic, Sonja PhD [//]; Bousdras, Konstantinos MD [P]; Pizzolitto, Stefano MD [sharp]; De Maglio, Giovanna BSc [sharp]; den Bakker, Michael A. MD **; Di Francesco, Lisa MD ++; Kalil, Ricardo K. MD ++++; Athanasou, Nicholas A. MD [S][S]; O'Donnell, Paul MD [//][//]; McCarthy, Edward F. MD [sharp][sharp]; Flanagan, Adrienne M. MD, PhD, FRCPath * [//] [P] (Source: The American Journal of Surgical Pathology)...
POSTED 03/26/2008 at 06:38 PM --

|
Surgical approaches: postoperative care and complications “posterolateral–far lateral transcondylar approach to the ventral foramen magnum and upper cervical spinal canal”
Abstract
Background Lesions that affect the lower clivus, foramen magnum, the craniocervical junction, and the upper cervical spinal canal that
are anterolateral and at times intradural require access ventral to the cerebellum and spinal cord. The posterolateral transcondylar
approach provides such a route. In addition, posterior craniocervical stabilization can be accomplished at the same time.
The author has reviewed the technique as well as the surgical results here.
Materials and methods The posterolateral transcondylar approach to the craniocervical junction was utilized in children with schwannoma, meningioma,
and chordoma affecting the cervicomedullary junction. Other entities such as neurenteric cysts and hemangioblastoma were also
seen. Extradural tumors such as aneurysmal bone cysts of the atlas and the axis vertebrae as well as proatlas segmentation
abnormalities and bone tumors were seen. The stability of the craniocervical junction was assessed preoperatively so that
a fusion procedure could be accomplished at the same operative setting, if necessary. Preoperative evaluation of the lower
cranial nerves was vital. The surgical procedure was accomplished in the prone position. The occipital bone removal was carried
out up to the sigmoid sinus and toward the jugular bulb. Relocation of the vertebral artery was made at the atlas vertebra
and thus provided posterolateral exposure into the posterior fossa and upper cervical spinal canal. Occipital condyle removal
was limited to one-third of the medial occipital condyle.
Results Twenty-five children underwent a posterolateral transcondylar approach. New lower cranial nerve dysfunction occurred in two
and only one required a tracheostomy. This was seen in a child with clivus chordoma. A complete removal was accomplished in
meningioma and schwannoma as well as in neurenteric cyst and hemangioblastoma. Clivus chordomas required more than one surgical
procedure. The tumors of the bone were all treated with simultaneous fusion.
Conclusions The posterolateral transcondylar route is a versatile avenue to approach a variety of lesions ventrolateral to the brain stem
and upper cervical cord. Exposure is quite satisfactory with minimal or no retraction of important neurovascular structures
in the region. Modifications of this theme can be applied as the lesions require.
Content Type Journal ArticleCategory Special Annual IssueDOI 10.1007/s00381-008-0597-5Authors
Arnold H. Menezes, University of Iowa Hospitals and Clinics Department of Neurosurgery 200 Hawkins Drive, 1824 JPP Iowa City Iowa 52242 USA
Journal Child's Nervous SystemOnline ISSN 1433-0350Print ISSN 0256-7040 (Source: Child's Nervous System)...
POSTED 03/26/2008 at 09:51 AM --

|
Extranotochordal extralaryngeal chordoma: a case report.
Extranotochordal extralaryngeal chordoma: A case report.
Auris Nasus Larynx. 2008 Mar 20;
Authors: Bumber Z, Krizanac S, Janjanin S, Bilic M, Bumber B
Chordomas are rare, malignant, slowly growing neoplasms which develop from vestigial remnants of the fetal notochord. Most chordomas arise in the sacrococcygeal and spheno-occipital region. Extranotochordal chordomas are extremely unusual. A case of extranotochordal chordoma with extralaryngeal localization is described. A 73-year-old male presented with swallowing difficulties and hoarseness. Contrast-enhanced magnetic resonance imaging of the neck revealed a well-encapsulated tumor mass that was well enhanced and located in the left retrolaryngeal space at the level of C4, dislocating the larynx to the right. Left radical neck dissection and tumor extirpation were performed. The tumor had not invaded cervical vertebra and the surrounding soft tissue but superficial erosions of the ossificated thyroid and cricoid cartilage were found. High-power pathologic examination and immunohistochemistry defined the lesion as a dedifferentiated type of chordoma. The patient received adjuvant radiotherapy. Four years after the surgery, the patient has been free from tumor recurrence.
PMID: 18358656 [PubMed - as supplied by publisher] (Source: Auris, Nasus, Larynx)...
POSTED 03/19/2008 at 11:00 PM --

|
[extensive lower clivus chordomas.]
[Extensive lower clivus chordomas.]
Neurochirurgie. 2008 Mar 20;
Authors: Fournier HD, Hue AS, Laccourreye L
BACKGROUND AND PURPOSE: Clival chordomas are rare skull-base tumors with local malignant behavior. Their control and removal remain difficult because of their anatomical location and because of their extensions. The goal of the treatment is complete surgical removal in a single stage if possible, with minimal deficits, followed by proton therapy. If the tumor remains extradural for a while, it finally progresses through the dura backwards to reach and displace the brain stem and upper cervical cord. Its anterior extension in the retropharyngeal space offers a logical opportunity and many advantages to use an anterior approach. METHODS: With three consecutive cases, we try to demonstrate that the unilateral transmandibular approach offers a large exposure of the lower clivus, the foramen magnum in its ventral part, the ipsilateral infratemporal fossa and C1 to C3. Surgical complications concern the lower cranial nerves, including the hypoglossal. Serous otitis media is possible in case of opened Eustachian tube. Tracheostomy is needed because of a transient tongue oedema. RESULTS: The unilateral transmandibular approach enabled to anatomical and physiological nasal preservation, large operative field facilitating dural closure and tumor removal, with acceptable cosmetic results and sequellae considering the natural course and prognosis of the tumor. CONCLUSIONS: This approach seems to be very useful to reach and removed extensive lower chordomas.
PMID: 18359050 [PubMed - as supplied by publisher] (Source: Neuro-Chirurgie)...
POSTED 03/19/2008 at 11:00 PM --

|
You asked, we answered: duke student answered your cancer questions
Josh Sommer's responses to viewer questions about his battle with chordoma. (Source: ABC News: Health)...
POSTED 03/16/2008 at 04:19 PM --

|
Thoracic chordoma: an unusual presentation of the spinal tumor.
Page: 239DOI: 10.1097/MAJ.0b013e3180ebeac3Authors: WANG, TSAI-JUNG; SHU, SHU-HSIEN; LIN, CHUN-WEI; CHEN, LUNG-FANG; LIN, TING-CHAO; CHIEN, HSIH-SHIN CHANG; CHAN, KWAN-YEE MD; LEE, MING-YUAN MD; WANG, YONG ALISON MD, PhD; HUANG, CHUNG-JEN MD; LIU, CHIA-CHUAN MD (Source: The American Journal of the Medical Sciences)...
POSTED 03/15/2008 at 02:29 AM --

|
|
|
|
|
|
|
|
 |
|
|
|
|
|
IMPORTANT NOTICE: The information provided on this site is intended for your general knowledge only and is not a substitute for professional
medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a
qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
|
|
|
|
|
|
|
|
Featured Product! |
 |
|
Arthrit-Eze |
|
Arthrit-Eze is the most advanced
formula on the market today |
|
It offers potential relief and
rejuvenation for all forms of arthritis, safely, naturally and without side
effects!
NO PRESCRIPTION REQUIRED! |
|
CLICK HERE for more info... |
|
|